Mereo BioPharma Group Plc (MREO)
0.3496
0.00 (0.00%)
USD |
NASDAQ |
Mar 26, 12:12
Mereo BioPharma Group Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0656M |
| Autolus Therapeutics Plc | 35.49M |
| Bicycle Therapeutics Plc | -0.5731M |
| AstraZeneca PLC | -1.501B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.670M |
| Cash from Financing (Quarterly) | 0.0387M |
| Free Cash Flow | -31.36M |
| Free Cash Flow Per Share (Quarterly) | -0.0482 |
| Free Cash Flow to Equity (Quarterly) | -7.475M |
| Free Cash Flow to Firm (Quarterly) | -7.648M |
| Free Cash Flow Yield | -56.44% |